One-step competitive immunochromatographic assay for semiquantitative determination of lipoprotein(a) in plasma.

Numerous studies have associated high concentrations of lipoprotein(a) [Lp(a)] with atherosclerosis. We developed a rapid, one-step competitive immunochromatographic assay to measure Lp(a) in plasma. The assay is performed on a nitrocellulose membrane strip and the result is determined by a visual readout of rust-colored colloidal selenium. The assay is based on the principle that Lp(a) in the sample will compete with Lp(a)-coated colloidal selenium for binding to the anti-Lp(a) monoclonal antibody immobilized on the assay strip in the format of four ladder bars. The number of capture bars that appear as a result of the formation of colloidal selenium color is proportional to the concentration of the Lp(a) protein in the samples. The strip assay semiquantitatively measures Lp(a) concentrations ranging from 0 to 180 mg/L of Lp(a) protein in serum, plasma, or fingerstick whole-blood samples. This assay appears very useful for quick identification of individuals with above-normal concentrations of plasma Lp(a) protein (> 70 mg/L), and has potential for monitoring a patient's response to treatment with Lp(a)-lowering drugs.

[1]  W. Hazzard,et al.  Immunochemical quantification of human plasma Lp(a) lipoprotein , 2006, Lipids.

[2]  D. Genser,et al.  INCREASED LIPOPROTEIN(a) LEVELS IN CHILDREN WITH FAMILIAL HYPERCHOLESTEROLAEMIA , 1988, The Lancet.

[3]  H. Towbin,et al.  Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications. , 1979, Proceedings of the National Academy of Sciences of the United States of America.

[4]  A. Scanu,et al.  Heterogeneity of human plasma lipoprotein (a). Isolation and characterization of the lipoprotein subspecies and their apoproteins. , 1984, The Journal of biological chemistry.

[5]  G. Michiels,et al.  Lipoprotein(a) quantified by an enzyme-linked immunosorbent assay with monoclonal antibodies. , 1989, Clinical chemistry.

[6]  Smith Rc,et al.  Pre-beta (or alpha 2) lipoprotein of high density in human blood. , 1971 .

[7]  A. Scanu,et al.  Physicochemical properties of apolipoprotein(a) and lipoprotein(a-) derived from the dissociation of human plasma lipoprotein (a). , 1986, The Journal of biological chemistry.

[8]  E. Boerwinkle,et al.  Defects in the low density lipoprotein receptor gene affect lipoprotein (a) levels: multiplicative interaction of two gene loci associated with premature atherosclerosis. , 1989, Proceedings of the National Academy of Sciences of the United States of America.

[9]  V. Armstrong,et al.  The association between serum Lp(a) concentrations and angiographically assessed coronary atherosclerosis. Dependence on serum LDL levels. , 1986, Atherosclerosis.

[10]  R. Zechner,et al.  Interaction of lipoprotein Lp(a) and low density lipoprotein with glycosaminoglycans from human aorta. , 1988, Arteriosclerosis.

[11]  K. Berg.  A NEW SERUM TYPE SYSTEM IN MAN--THE LP SYSTEM. , 2009, Acta pathologica et microbiologica Scandinavica.

[12]  M. Blombäck,et al.  PLASMINOGEN ACTIVATOR INHIBITOR IN PLASMA: RISK FACTOR FOR RECURRENT MYOCARDIAL INFARCTION , 1987, The Lancet.

[13]  M. Frick,et al.  Lp(a) Lipoprotein/pre‐β1‐lipoprotein, serum lipids and atherosclerotic disease , 1976, Clinical genetics.

[14]  W. Hazzard,et al.  Radioimmunoassay of human plasma Lp(a) lipoprotein. , 1977, Journal of lipid research.

[15]  G. Cazzolato,et al.  "Sinking" lipoprotein in normal, hyperlipoproteinaemic and atherosclerotic patients. , 1975, Clinica chimica acta; international journal of clinical chemistry.

[16]  D. Margulies,et al.  A simple method for polyethylene glycol-promoted hybridization of mouse myeloma cells , 1977, Somatic cell genetics.

[17]  G. Utermann,et al.  Lp(a) Phenotyping by Immunoblotting with Polyclonal and Monoclonal Antibodies , 1988, Arteriosclerosis.

[18]  G. Dahlén,et al.  Evidence for increased levels of plasminogen activator inhibitor and tissue plasminogen activator in plasma of patients with angiographically verified coronary artery disease. , 1989, European heart journal.

[19]  D. Collen.  On the Regulation and Control of Fibrinolysis , 1980, Thrombosis and Haemostasis.

[20]  A. Gotto,et al.  Human plasma lipoprotein [a]. Structural properties. , 1983, The Journal of biological chemistry.

[21]  E. Chen,et al.  cDNA sequence of human apolipoprotein(a) is homologous to plasminogen , 1987, Nature.

[22]  M. Frick,et al.  Lp(a) lipoprotein and pre‐β1‐lipoprotein in patients with coronary heart disease , 1974, Clinical genetics.

[23]  M. Seishima,et al.  Enzyme-linked immunosorbent assay of lipoprotein(a) in serum and cord blood. , 1988, Clinica chimica acta; international journal of clinical chemistry.

[24]  N. Tolbert,et al.  A modification of the Lowry procedure to simplify protein determination in membrane and lipoprotein samples. , 1978, Analytical biochemistry.

[25]  J. Morrisett,et al.  Quantitation, isolation, and characterization of human lipoprotein (a). , 1986, Methods in enzymology.